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Introduction
Th   e United States Government is committed to support-
ing the establishment and sustainability of comprehensive 
global disease surveillance. Many agencies across the U.S. 
Government, working in a coordinated fashion in every 
region of the world, are engaged in this essential mission. 
Th  is commitment is based on the recognition that a 
weakness in the surveillance system in one part of the 
world is a weakness for the entire globe, and that every 
nation needs the infrastructure to prepare for, respond 
to, and recover from health emergencies. Th  is work is 
also in support of Article 44 of the Revised International 
Health Regulations [IHR (2005)], which directs countries 
that are able to provide assistance to other nations 
through technical cooperation and ﬁ  nancial resources to 
develop, strengthen and maintain core disease surveil-
lance capacities [1].
Several U.S. Government agencies have been engaged 
in eﬀ  orts to support global disease surveillance for years, 
and in some cases, for decades. Agencies work together 
to coordinate eﬀ  orts, ensure sustainable programs, and 
address the needs of partner countries. In this paper, we 
present an overview of each individual agency, their 
particular interests and strengths, and the focus of their 
operations. Th  is overview is intended to help the inter-
national community better understand the U.S. Govern-
ment partner agencies, how they operate, and how they 
diﬀ  er from their partners.
U.S. Government agencies engaged in supporting 
global disease surveillance
Th  e following section provides a brief overview of each 
U.S. Government agency. Agencies are presented in 
alphabetical order.
U.S. Agency for International Development
Emerging Pandemic Threats Program
Th   e U.S. Agency for International Development (USAID) 
launched the Emerging Pandemic Th   reats (EPT) program 
[2] to aggressively preempt or combat diseases that could 
spark future pandemics by emphasizing early identi  ﬁ    ca-
tion of, and response to, dangerous pathogens in animals 
before they can become signiﬁ   cant threats to human 
health. Using a risk-based approach, the EPT program 
builds on USAID’s experience in disease surveillance, 
training, and outbreak response to focus on geographic 
areas where these threats are most likely to emerge. Th  e 
EPT program draws on expertise from across the animal- 
and human-health sectors to build regional, national, and 
local capacities for early disease detection, laboratory-
based disease diagnosis, rapid disease response and 
containment, and risk reduction. Th  ese eﬀ  orts target a 
limited number of geographic areas, known as “hot 
spots,” where new disease threats have emerged in the 
past. Th  e EPT program focuses on “hot spots” in the 
Congo Basin of East and Central Africa, the Mekong 
region and other “hot spots” in Southeast Asia, the 
Amazon region of South America, and the Gangetic Plain 
of South Asia.
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Public HealthUSAID anticipates that the EPT program will develop 
predictive models for early identiﬁ   cation of viral and 
other biological threats in “hot spot” regions and that it 
will enhance regional, national, and local capacities for 
surveillance, laboratory diagnosis, and ﬁ  eld epidemiology 
in both the animal- and human-health sectors in these 
areas. Th  e EPT program’s investments in disease detec-
tion and response will be reﬂ   ected in their routine 
application in the management of more normative 
diseases in these areas, such as malaria, cholera, and 
meningitis. Th  ese contributions more broadly support 
the tenets outlined in the IHR(2005) and equivalent 
international health standards of the World Organization 
for Animal Health (OIE).
U.S. Department of Agriculture
Agricultural Research Service
Th  e Agricultural Research Service (ARS) [3] is the 
principal in-house research agency of the U.S. Depart-
ment of Agriculture (USDA). ARS is actively engaged in 
implementing research programs that support global 
disease surveillance initiatives for plants and animals, 
including emerging diseases and zoonotic agents that 
pose a threat to human health. ARS research pro  grams 
support disease surveillance initiatives in several U.S. 
Government agencies, such as USDA’s Animal and Plant 
Health Inspection Service (APHIS), the Centers for 
Disease Control and Prevention (CDC), and the State 
Department’s Biosecurity Engagement Program (BEP). In 
addition, ARS actively collaborates with international 
part  ners worldwide on research projects dedicated to 
support disease surveillance programs. ARS is one of the 
founding members of the Global Foot-and-Mouth 
Disease Research Alliance (GFRA), which has as its 
primary mission to support the United Nations’ Food 
and Agricultural Organization (FAO) and OIE global 
eﬀ  orts to control and eradicate Foot-and-Mouth Disease 
(FMD).
Animal and Plant Health Inspection Service
USDA’s Animal and Plant Health Inspection Service 
(APHIS) [4] plays a signiﬁ  cant role in increasing global 
food security by promoting technology- and science-based 
solutions and capacity-building activities in countries 
around the world. A cornerstone of this concept is 
enhanced coordination between the agricul  ture and public 
health sectors for disease surveillance, detection, and 
control. APHIS plays a direct role in public health, 
especially in eﬀ  orts to mitigate veterinary diseases and 
ensure the healthfulness of agricultural practices and 
products. APHIS has programs in disease detection and 
surveillance, disease exclusion, animal disease infor  ma  tion 
systems, and emergency response. Technical exper  tise is 
delivered through APHIS’s Centers for Epidemiology and 
Animal Health, the National Surveillance Unit, the 
National Veterinary Services Laboratory and the National 
Animal Health Laboratory Network.
U.S. Department of Defense
Armed Forces Health Surveillance Center, Division of Global 
Emerging Infection Surveillance and Response
Th   e Division of Global Emerging Infections Surveillance 
and Response (GEIS) of the Armed Forces Health 
Surveillance Center (AFHSC) [5] coordinates a global 
program of infectious disease surveillance under the ﬁ  ve 
militarily relevant pillars of respiratory infections, gastro-
intestinal infections, antimicrobial resistant organisms, 
febrile and vector-borne infections, and sexually trans-
mitted infections. In addition to surveil  lance activities, 
capacity building, training, and commu  ni  cation are 
important dimensions to the program. Currently, GEIS 
operates projects in over 80 countries through  out the 
world, and Department of Defense overseas laboratories 
perform the majority of the work outside the U.S. from 
their ﬁ   xed assets in Cairo, Egypt; Nairobi, Kenya; 
Bangkok, Th   ailand; Lima, Peru; and Southeast Asia.
GEIS releases requests for proposals, evaluated through 
a competitive proposal review process, with emphasis on 
identiﬁ  ed gap areas. Recent emphases are on standard-
ization, expanded military-to-military engagements, and 
fusion of surveillance activities into those of the host 
nations, thus enhancing capacity building eﬀ  orts. 
Compliance with IHR(2005) provides the framework for 
these eﬀ   orts, while fostering open, professional, and 
supportive relationships between U.S. Government and 
host country public health assets.
Chemical and Biological Defense Program
Th   e Chemical and Biological Defense Program, [6] under 
the Assistant Secretary of Defense for Nuclear and 
Chemical and Biological Defense Programs, houses both 
the Joint Program Executive Oﬃ   ce  for  Chemical 
Biological Defense and the Joint Science and Technology 
Oﬃ   ce. Th   e Joint Program Executive Oﬃ   ce for Chemical 
Biological Defense supports the biosurveillance func-
tional areas of global awareness, passive monitoring, 
active surveillance, pathogen identiﬁ  cation, and pathogen 
characterization. Th  e Joint Science and Technology 
Oﬃ   ce works to develop detection systems, broad spec-
trum next generation diagnostics and disease models to 
support advancing surveillance systems. Th  is oﬃ   ce also 
focuses on enhancing early warning informatics, which 
includes data collection, reporting and analysis.
Defense Threat Reduction Agency, Cooperative Biological 
Engagement Program
Th  e mission of the Defense Th  reat Reduction Agency’s 
(DTRA) Cooperative Biological Engagement Program 
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related materials, expertise, other emerging infectious 
disease risks, and to prevent these agents from reaching 
any state or non-state actors who may use them against 
the United States or its allies. Th  e program focuses on 
delivering tailored approaches that recognize and build 
upon partner countries’ indigenous capacities. Th  e  CBEP 
mission is achieved through execution of three key 
product lines: Biological Safety & Security capacity 
building; Disease Surveillance, Detection, Diagnosis, and 
Reporting; and Cooperative Biological Research. Th  rough 
these three product lines the Program aims to secure 
dangerous pathogens; promote open and active disease 
reporting and response; and advance transparent research 
to understanding pathogens and developing potential 
counter  measures. CBEP works with a number of 
partner countries to assist in compliance with the 
IHR(2005), the OIE reporting guidelines, and the FAO 
reporting guide  lines. CBEP also works with partner 
countries to imple  ment a disease surveillance, detec-
tion, diagnosis, report  ing, and response system that is 
safe, secure, and sustainable; and to integrate existing 
surveillance eﬀ  orts to improve global disease surveil-
lance and ensure timely, accurate situational awareness 
of infectious disease threats.
U.S. Department of Energy
Los Alamos National Laboratory
Los Alamos National Laboratory (LANL) [8] is a premier 
national security research institution under the Depart-
ment of Energy (DOE), delivering scientiﬁ  c and engineer-
ing solutions for crucial and complex problems. A broad 
multi-agency research and development program is 
pursued at LANL in support of global infectious disease 
surveillance. Th  ese eﬀ  orts include the development and 
application of enabling information science and tech-
nology, high throughput bioanalytical systems, character-
ization of host-pathogen interactions, and ﬁ  eld deploy-
able detection and identiﬁ  cation systems.
Th   e Department of Energy Joint Genome Institute, of 
which LANL is a principal component, is a major 
national microbial genome sequencing resource that has 
completed over 30 percent of the bacterial genomes 
sequenced nationwide. Th   e High Th  roughput  Laboratory 
Network (HTLN) is a joint eﬀ  ort with the University of 
California Los Angeles, and is designed to process and 
analyze hundreds of samples per day in order to support 
global surveillance of infectious diseases of both health 
and security concern and to establish a global network 
for information/data management, sharing and know-
ledge generation. High performance computing resources 
support immune and epidemiological modeling and 
pathogen feature recognition and pathogen signature 
detection assay design. Th   rough its many collaborations, 
LANL strives to develop eﬃ   cacious  cost-eﬀ  ective 
surveillance technologies and an enabling knowledge 
base to achieve a sustainable global infectious disease 
surveillance network.
U.S. Department of Health and Human Services
Th   e Department of Health and Human Services (HHS) is 
the technical agency for human health, disease surveil-
lance, and the public health response to emer  gen  cies and 
disasters. Th  e IHR(2005) Program sits in Th  e Oﬃ   ce of 
the Assistant Secretary for Preparedness and Response 
(ASPR) within HHS, [9] and works closely with the 
oﬃ   cial National Focal Point for the United States- the 
Operations Center for the Oﬃ   ce of the Secretary of HHS. 
Th   e Centers for Disease Control and Prevention (CDC) — 
programs described below—is part of HHS.
Centers for Disease Control and Prevention
Global Disease Detection Program
Th   e Global Disease Detection program in the Division 
of Global Disease Detection and Emergency Response 
[10] is CDC’s principal program for developing and 
strengthen  ing global public health capacity to rapidly 
identify and contain naturally occurring or man-made 
disease threats from around the world. Th  e program 
presently comprises eight international regional centers 
and CDC headquarters components. Th   e GDD regional 
centers, located in every WHO region of the world, 
work with country partners to implement disease 
detection and response trainings, protocols, and 
interventions. Th   e centers’ expertise includes training in 
ﬁ  eld epidemiology and laboratory methods, surveillance 
and response for emerging infectious disease threats, 
assistance with pandemic inﬂ  uenza  preparedness, 
promotion of zoonotic disease investigations and 
control eﬀ   orts, risk communi  cations, and laboratory 
biosafety and improved labora  tory systems. A cadre of 
US-based CDC scientists provides technical expertise 
to the regional centers. In recognition of GDD’s capacity 
development activities, WHO designated GDD as a 
Collaborating Center for Implementation of IHR 
National Surveillance and Response Capacity in 
December 2009.
An integral part of GDD is the GDD Operations Center 
located at CDC headquarters. Th  is innovative epidemic 
intelligence and response operations unit uses non-
traditional surveillance methods and information from 
internationally-based CDC staﬀ   and partners to provide 
early warning about international disease threats thereby 
positioning CDC to respond rapidly when assistance is 
requested. CDC is a key partner in Global Outbreak Alert 
Response Network (GOARN) and participation of CDC 
staﬀ    in GOARN teams is coordinated by the GDD 
Operations Center.
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Like the Global Disease Detection and Emergency 
Response Division, the Division of Public Health Systems 
and Workforce Development [11] sits in the Center for 
Global Health at CDC. Th   e purpose of this division is to 
work with Ministries of Health and other public health 
partners to build strong public health systems and work-
force capacity. Th  e Division operates several training 
programs, including the Field Epidemiology Training 
Program (FETP), the Field Epidemiology and Laboratory 
Training Program (FELTP), and the Sustainable Manage-
ment Development Program. FETPs and FELTPs are 
typically Ministry of Health-based in-service training 
programs in applied epidemiology aimed at strengthening 
countries’ epidemiology, surveillance, outbreak response, 
and laboratory systems and workforce.  As of mid-2010, 
the division is supporting 15 FETP/FELTPs covering 29 
countries with another 8 programs covering 11 countries 
currently in development.  An additional 20 programs, 
previously supported by CDC, are operating independently.
Th  e division is also collaborating extensively with the 
World Health Organization’s Regional Oﬃ   ce for Africa 
(WHO/AFRO) on implementing the Integrated Disease 
Surveillance and Response (IDSR) strategy.  Th  e IDSR 
strategy aims to improve surveillance and response 
capacity in African countries and is WHO/AFRO’s 
primary strategy for improving early detection and 
response to infectious disease outbreaks.
U.S. Department of State
Biosecurity Engagement Program
Th   e U.S. Department of State manages America’s relation-
ships with foreign governments, international organiza-
tions, and the people of other countries. Th  e Biosecurity 
Engagement Program (BEP) [12] seeks to engage biological 
scientists and combat biological threats worldwide by 
providing assistance to improve biosecurity and biosafety, 
conduct cooperative research, and improve infectious 
disease detection and surveillance. Speciﬁ  cally,  BEP 
provides assistance in: biosafety and biosecurity, through 
technical consultations, risk assessments, and training 
courses that build human capacity and internal expertise 
to create a sustainable culture of laboratory biorisk manage-
ment; disease detection and control, by strengthen  ing the 
capacity for public health and veterinary health systems to 
detect, report, and control infectious disease outbreaks; 
scientist engagement, by encouraging a safe, secure and 
sustainable bioscience capacity through joint scientiﬁ  c 
collaborations designed to help prevent, detect, and 
respond to biological threats; and sustainable capacity, with 
a focus on long-term sustainability and capacity build  ing 
that creates an infrastructure for biorisk management.
BEP leverages technical resources and experts from 
numerous U.S. agencies, universities, international 
organi za tions,  NGOs, and the National Academies of 
Sciences to meet its core objectives. In addition to inter-
agency and organizational collaborations, BEP works 
closely with host-country governments, U.S. Embassies, 
and other nations to identify needs and implement 
assistance necessary to ensure safe, secure, and 
sustainable bioscience capacity, while achieving the larger 
goal of reducing global biological risks. BEP eﬀ  orts are 
threat-driven and designed to prevent, detect, and 
respond to both existing and emerging global biological 
threats.
Discussion
Eﬀ   ective global engagement in support of disease 
surveillance capacity building requires coordination and 
partnership. Each of the above-mentioned agencies and 
oﬃ     ces has unique resources and technical expertise. 
Th   ese entities ﬁ  rst must coordinate with each other and 
then with international partners to ensure that global 
engagement eﬀ  orts are eﬃ   cient, build oﬀ   of each other’s 
expertise, and are best combined to promote eﬀ  ective 
disease surveillance capacity building. Th  is internal co-
ordi  nation is not without challenges, as each entity has 
diﬀ  erent organizational cultures, administrative processes, 
and substantive expertise. Agencies do, however, actively 
try to work around these challenges, and use the White 
House National Security Staﬀ    as an overarching co-
ordinating body.
In addition to internal U.S. coordination, agencies 
require a strong working relationship with partner 
countries in order to be most eﬀ  ective. Ideal country 
engagement involves a commitment on the part of the 
partner country to an agreed upon strategy for engage-
ment that includes planning for ﬁ  nancial sustain  ability 
and human resources needs. Eﬀ  ective engagement also 
requires the designation of points of contact for co-
ordinating eﬀ  orts, and a commitment to open commu-
nication with the assisting entity. Additionally, it requires 
that both the U.S. and its partner country recognize that 
their individual perception of needs and priorities may 
diﬀ  er, and that strong relationships and communications 
are essential to successful engagement.
Conclusion
Th  e U.S. is committed to providing resources and 
expertise to enhance global disease surveillance and 
assist in building a comprehensive, eﬀ  ective and eﬃ   cient 
public health infrastructure. Each U.S. Government 
agency that is engaged in building global disease 
surveillance capacity brings its own particular expertise 
and interest to the endeavor. Th  ese agencies, however, 
work closely in coordi  nation both with other U.S. entities 
as well as with partner countries and organizations, 
building on individual expertise.
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